Search Results

There are 14830 results for: content related to: Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study

  1. Association between non-steroidal anti-inflammatory drugs and keratinocyte carcinomas of the skin among participants in the Veterans Affairs Topical Tretinoin Chemoprevention Trial

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 9, September 2011, Pages: 922–929, Anthony P. Nunes, Kate L. Lapane, Martin A. Weinstock and VATTC Trial Group

    Article first published online : 18 JUN 2011, DOI: 10.1002/pds.2142

  2. Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 700–708, Qian Li, Robert J. Glynn, Nancy A. Dreyer, Jun Liu, Helen Mogun and Soko Setoguchi

    Article first published online : 14 MAY 2011, DOI: 10.1002/pds.2146

  3. Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 619–625, Hedi Schelleman, John R. Pollard, Craig Newcomb, Clyde E. Markowitz, Warren B. Bilker, Mary B. Leonard and Sean Hennessy

    Article first published online : 28 APR 2011, DOI: 10.1002/pds.2141

  4. Off-label prescribing patterns of antidepressants in children and adolescents

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 2, February 2012, Pages: 137–144, Euni Lee, Anna R. Teschemaker, Rosemary Johann-Liang, Gina Bazemore, Martin Yoon, Kye-Sik Shim, Marlon Daniel, Jerome Pittman and Anthony K. Wutoh

    Article first published online : 28 APR 2011, DOI: 10.1002/pds.2145

  5. Risk of hospitalization for upper gastrointestinal adverse events associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study in Taiwan

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 763–771, Chia-Hsuin Chang, Hsi-Chieh Chen, Jou-Wei Lin, Chuei-Wen Kuo, Wen-Yi Shau and Mei-Shu Lai

    Article first published online : 25 MAY 2011, DOI: 10.1002/pds.2140

  6. Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1088–1097, Andrea V. Margulis, Niteesh K. Choudhry, Colin R. Dormuth and Sebastian Schneeweiss

    Article first published online : 28 APR 2011, DOI: 10.1002/pds.2144

  7. Market withdrawal of new molecular entities approved in the United States from 1980 to 2009

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 772–777, Zaina P. Qureshi, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio, Kurt B. Stevenson and Sheryl L. Szeinbach

    Article first published online : 14 MAY 2011, DOI: 10.1002/pds.2155

  8. Safety profile of oseltamivir during the 2009 influenza pandemic

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 532–543, Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith and Viswanathan Niranjan

    Article first published online : 29 MAR 2011, DOI: 10.1002/pds.2136

  9. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 626–634, Dominik Rottenkolber, Sven Schmiedl, Marietta Rottenkolber, Katrin Farker, Karen Saljé, Silke Mueller, Marion Hippius, Petra A. Thuermann, Joerg Hasford and for the Net of Regional Pharmacovigilance Centers

    Article first published online : 8 MAR 2011, DOI: 10.1002/pds.2118

  10. Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 718–728, Kueiyu Joshua Lin, Luis A. García Rodríguez and Sonia Hernández-Díaz

    Article first published online : 27 MAY 2011, DOI: 10.1002/pds.2153

  11. Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 747–753, Pernelle Noize, Haleh Bagheri, Geneviève Durrieu, Françoise Haramburu, Nicholas Moore, Patrick Giraud, Michel Galinier, Jacques Pourrat and Jean-Louis Montastruc

    Article first published online : 16 MAR 2011, DOI: 10.1002/pds.2128

  12. Incidence of interstitial lung disease in patients with mesothelioma in the west part of Japan

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 643–652, Shuko Nojiri, Kenichi Gemba, Keisuke Aoe, Katsuya Kato, Takuhiro Yamaguchi, Tsugumichi Sato, Kiyoshi Kubota and Takumi Kishimoto

    Article first published online : 18 MAR 2011, DOI: 10.1002/pds.2123

  13. Paediatric post-marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adults

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 608–618, Beate Aurich-Barrera, Lynda Wilton, David Brown and Saad Shakir

    Article first published online : 23 FEB 2011, DOI: 10.1002/pds.2105

  14. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 514–522, Johanna Jyrkkä, Hannes Enlund, Piia Lavikainen, Raimo Sulkava and Sirpa Hartikainen

    Article first published online : 9 FEB 2011, DOI: 10.1002/pds.2116

  15. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 567–582, Rolf Teschke, Wolfgang Schmidt-Taenzer and Albrecht Wolff

    Article first published online : 29 MAR 2011, DOI: 10.1002/pds.2127

  16. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 488–496, Alessandro Nobili, Carlotta Franchi, Luca Pasina, Mauro Tettamanti, Marta Baviera, Lara Monesi, Carla Roncaglioni, Emma Riva, Ugo Lucca, Angela Bortolotti, Ida Fortino and Luca Merlino

    Article first published online : 24 JAN 2011, DOI: 10.1002/pds.2108

  17. The national burden of E-code-identified adverse drug events among hospitalized children using a national discharge database

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 866–878, Namita L. Tundia, Pamela C. Heaton and Christina M.L. Kelton

    Article first published online : 14 MAY 2011, DOI: 10.1002/pds.2150

  18. Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic “matrix design”

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 675–683, Jeremy A. Rassen, Daniel H. Solomon, Robert J. Glynn and Sebastian Schneeweiss

    Article first published online : 30 MAY 2011, DOI: 10.1002/pds.2121

  19. Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 838–848, John Paul Leombruno, Geoffrey C. Nguyen, Paul Grootendorst, David Juurlink and Tom Einarson

    Article first published online : 17 JUN 2011, DOI: 10.1002/pds.2132

  20. Trends in emergency department visits attributable to acetaminophen overdoses in the United States: 1993–2007

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 810–818, Chenghui Li and Bradley C. Martin

    Article first published online : 18 JAN 2011, DOI: 10.1002/pds.2103